Testing effectiveness (Phase 2)UnknownNCT00003827What this trial is testingCombination Chemotherapy in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes ALZA 25
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT00274820What this trial is testingArsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative DisorderWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more Case Comprehensive Cancer Center 15
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT03523351What this trial is testingStudy of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant PainWho this might be right forMetastatic Solid Tumors of Metastatic Disease Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT01934790What this trial is testingRe-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone MetastasesWho this might be right forProstatic Neoplasms Bayer 45
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Post-approval studies (Phase 4)Study completedNCT02564107What this trial is testingIbandronate (Bondronat) in Participants With Metastatic Bone DiseaseWho this might be right forPain; Bone Neoplasms; Neoplasm Metastasis Hoffmann-La Roche 48
Early research (Phase 1)Active Not RecruitingNCT02890329What this trial is testingIpilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forPreviously Treated Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia, Myelodysplasia-Related+5 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Ended earlyNCT01465386What this trial is testingBortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in RemissionWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Myeloblastic Leukemia Without Maturation (M1)+9 more Fred Hutchinson Cancer Center 6
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00352001What this trial is testingLenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Mikkael Sekeres MD 37
Testing effectiveness (Phase 2)UnknownNCT01693770What this trial is testingPrimary Pain Palliation in Bone Metastases Treated With Magnetic Resonance-guided Focused UltrasoundWho this might be right forSecondary Malignant Neoplasm of Bone University of Roma La Sapienza 18
Large-scale testing (Phase 3)UnknownNCT00006045What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaWho this might be right forLeukemia Facet Biotech
Post-approval studies (Phase 4)Study completedNCT00211211What this trial is testingFREE Study - Fracture Reduction EvaluationWho this might be right forOsteopeniaOsteoporosisMultiple Myeloma+1 more Medtronic Spine LLC 300
Not applicableUnknownNCT06235034What this trial is testingDiagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT SimulationWho this might be right forBone Metastases British Columbia Cancer Agency 10
Testing effectiveness (Phase 2)Study completedNCT00083187What this trial is testingVNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk MyelodysplasiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Vion Pharmaceuticals 230
Early research (Phase 1)Ended earlyNCT00234000What this trial is testingAzacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Large-scale testing (Phase 3)Study completedNCT00004208What this trial is testingAntithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndromes Swiss Cancer Institute 86